The relationship between body mass index and sleep in women with risk factors for gestational diabetes mellitus

OnlinePublBackground: Both obesity and sleep disorders are common among women during pregnancy. Although prior research has identified a relationship between obesity and sleep disorders, those findings are from women later in pregnancy. Objective: To explore the relationships between self‐reported sleep duration, insufficient sleep and snoring with body mass index (BMI) among multiethnic women at risk of gestational diabetes mellitus (GDM)in early pregnancy.Methods: Cross‐sectional study of baseline data from women at risk of GDM enrolled in the Treatment of BOoking Gestational diabetes Mellitus (TOBOGM) multicentre trial across 12 Australian/Austrian sites. Participants completed a questionnaire before 20 weeks’ gestation to evaluate sleep. BMI 5 days/ month was higher in class II and class III obesity (1.38 (1.03–1.85) and 1.34 (1.01– 1.80), respectively), and the risk of snoring increased as BMI increased (1.59 (1.25– 2.02), 2.68 (2.07–3.48), 4.35 (3.21–5.88) to 4.96 (3.65–6.74), respectively)). Conclusions: Obesity is associated with insufficient sleep among pregnant women at risk of GDM. Snoring is more prevalent with increasing BMI.Pamela Acosta Reyes, Jincy Immanuel, William M. Hague, Helena Teede, Emily Hibbert, Christopher J. Nolan, Michael J. Peek, Vincent Wong, Jeffrey R. Flack, Mark McLean, Raiyomand Dalal, Jürgen Harreiter, Alexandra Kautzky, Willer, Rohit Rajagopal, Arianne Sweeting, Glynis P. Ross, Ngai Wah Cheung, David Simmon

Area-wide management of fruit flies (Diptera: Tephritidae) in the Central Burnett district of Queensland, Australia.

Queensland fruit fly, Bactrocera tryoni (Froggatt), is the most serious pest of the native tephritid species in Australia and a significant market access impediment for fruit commodities from any area where this species is endemic. An area-wide management (AWM) program was implemented in the Central Burnett district of Queensland with the aim of improving fruit fly control and enhancing market access opportunities for citrus and other fruits produced in the district. The primary control measures adopted in the AWM system included bait spraying of commercial and non-commercial hosts and the year-round installation of male annihilation technology (MAT) carriers in both orchards and town areas. The MAT carrier used consisted of a dental wick impregnated with 1 ml cue-lure [4-(4-acetoxyphenol)-2-butanone] and 1 ml Malathion 500 EC in a plastic cup. The application of these control measures from 2003 to 2007 resulted in overall suppression of fruit fly populations across the entire district. Male trap catches at the peak activity time were reduced by 95% and overall fruit fly infestation in untreated backyard fruit of town areas reduced from 60.8% to 21.8%. Our results demonstrate remarkable improvement in fruit fly control and economic benefit to the Central Burnett horticulture. Therefore, commercial growers are continuing the AWM program as a long-term, industry funded activity, to provide an additional layer of phytosanitary security for market access of fruit commodities from this district

Aspirin for the prevention of pre-eclampsia in women with pre-existing diabetes: Systematic review

OnlinePublBackground: There is a lack of evidence for pre-eclampsia prophylaxis with aspirin in women with pre-existing diabetes mellitus (DM). Aims: To examine the evidence for aspirin in pre-eclampsia prophylaxis in women with pre-existing DM. Material and Methods: An electronic search using Ovid MEDLINE, Embase, CinicalTrials.gov and the Cochrane CENTRAL register of controlled trials through to February 2021 was performed. Reference lists of identified studies, previous review articles, clinical practice guidelines and government reports were manually searched. Randomised controlled trials (RCTs) of aspirin vs placebo for pre-eclampsia prophylaxis were included. Articles were manually reviewed to determine if cohorts included women with DM. The systematic review was performed following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. Data from included trials were extracted independently by two authors who also independently assessed risk of bias as per the Cochrane Handbook criteria version 5.1.0. Data were analysed using Rev-Man 5.4. Results: Forty RCTs were identified, of which 11 included a confirmed subset of women with DM; however, data were insufficient for meta-analysis. Meta-analysis of 930 women with DM, from individual patient data included in a systematic review and unpublished data from one of the 11 RCTs, showed a non-significant difference in the outcome of pre-eclampsia in participants treated with aspirin compared to placebo (odds ratio 0.58; 95% CI 0.20–1.71; P = 0.33). Conclusions: Pre-eclampsia risk reduction with aspirin prophylaxis in women with pre-existing DM may be similar to women without pre-existing DM. However, randomised data within this meta-analysis were insufficient, warranting the need for further studies within this high-risk group of women.Monica Zen, Rabbia Haider, David Simmons, Michael Peek, Christopher J. Nolan, Suja Padmanabhan, Shilpa Jesudason, Thushari I. Alahakoon, Ngai Wah Cheung, and Vincent W. Le

Physicochemical hazard assessment of ash and dome rock from the 2021 eruption of La Soufrière, St Vincent, for the assessment of respiratory health impacts and water contamination

La Soufrière, St Vincent, began an extrusive eruption on 27 December 2020. The lava dome was destroyed, along with much of the pre-existing 1979 dome, in explosive eruptions from 9–22 April 2021. Lava domes generate crystalline silica – inhalation of which can cause silicosis in occupational settings – which can become hazardous when dome material is incorporated into volcanic ash. La Soufrière ash (17 samples) was analysed, according to IVHHN protocols, to rapidly quantify crystalline silica and test for other health-relevant properties. The basaltic andesitic ash containe

S2: Physicochemical hazard assessment of ash and dome rock from the 2021 eruption of La Soufrière, St Vincent, for the assessment of respiratory impacts and water contamination

Particle size dat

S1: Physicochemical hazard assessment of ash and dome rock from the 2021 eruption of La Soufrière, St Vincent, for the assessment of respiratory impacts and water contamination

Further information on particle size analysis methods and information provided in IVHHN report of leachate data, on volcanic ash impacts on animal healt

S3: Physicochemical hazard assessment of ash and dome rock from the 2021 eruption of La Soufrière, St Vincent, for the assessment of respiratory impacts and water contamination

XRD dat

Greenhouse gas emissions in The Netherlands 1990-2011. National Inventory Report 2013

Total greenhouse gas emissions from The Netherlands in 2011 decreased by approximately 7 per cent compared with 2010 emissions. This decrease is mainly the result of decreased fuel combustion in the Energy sector (less electricity production) and in the petrochemical industry. Fuel use for space heating decreased due to the mild winter compared with the very cold 2010 winter. In 2011, total direct greenhouse gas emissions (excluding emissions from LULUCF – land use, land use change and forestry) in The Netherlands amounted to 194.4 Tg CO2 eq. This is approximately 9 per cent below the emissions in the base year 2 (213.2 Tg CO2 eq). This report documents the Netherlands’ 2012 annual submission of its greenhouse gas emissions inventory in accordance with the guidelines provided by the United Nations Framework Convention on Climate Change (UNFCCC), the Kyoto Protocol and the European Union’s Greenhouse Gas Monitoring Mechanism. The report comprises explanations of observed trends in emissions; a description of an assessment of key sources and their uncertainty; documentation of methods, data sources and emission factors applied; and a description of the quality assurance system and the verification activities performed on the data. Keywords: greenhouse gases, emissions, trends, methodology, climat

Perinatal Outcomes in Early and Late Gestational Diabetes Mellitus After Treatment From 24-28 Weeks' Gestation: A TOBOGM Secondary Analysis

OnlinePublObjective: In most gestational diabetes mellitus (GDM) studies, cohorts have included women combined into study populations without regard to whether hyperglycemia was present earlier in pregnancy. In this study we sought to compare perinatal outcomes between groups: women with early GDM (EGDM group: diagnosis before 20 weeks but no treatment until 24-28 weeks if GDM still present), with late GDM (LGDM group: present only at 24-28 weeks), and with normoglycemia at 24-28 weeks (control subjects). Research design and methods: This is a secondary analysis of a randomized controlled treatment trial where we studied, among women with risk factors, early (<20 weeks' gestation) GDM defined according to World Health Organization 2013 criteria. Those receiving early treatment for GDM treatment were excluded. GDM was treated if present at 24-28 weeks. The primary outcome was a composite of birth before 37 weeks' gestation, birth weight ≥4,500 g, birth trauma, neonatal respiratory distress, phototherapy, stillbirth/neonatal death, and shoulder dystocia. Comparisons included adjustment for age, ethnicity, BMI, site, smoking, primigravity, and education. Results: Women with EGDM (n = 254) and LGDM (n = 467) had shorter pregnancy duration than control subjects (n = 2,339). BMI was lowest with LGDM. The composite was increased with EGDM (odds ratio [OR] 1.59, 95% CI 1.18-2.12)) but not LGDM (OR 1.19, 95% CI 0.94-1.50). Induction of labor was higher in both GDM groups. In comparisons with control subjects there were higher birth centile, higher preterm birth rate, and higher rate of neonatal jaundice for the EGDM group (but not the LGDM group). The greatest need for insulin and/or metformin was with EGDM. Conclusions: Adverse perinatal outcomes were increased with EGDM despite treatment from 24-28 weeks' gestation, suggesting the need to initiate treatment early, and more aggressively, to reduce the effects of exposure to the more severe maternal hyperglycemia from early pregnancy.David Simmons, Jincy Immanuel, William M. Hague, Helena Teede, Christopher J. Nolan, Michael J. Peek, Jeff R. Flack, Mark McLean, Vincent Wong, Emily J. Hibbert, Alexandra Kautzky-Willer, Jurgen Harreiter, Helena Backman, Emily Gianatti, Arianne Sweeting, Viswanathan Mohan, and N. Wah Cheung, on behalf of the TOBOGM Research Grou